Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function
1 other identifier
interventional
200
1 country
1
Brief Summary
The main aim of the study is to validate the algorithms developed to analyze the signals from the various sensors contained in the magneto-inertial control units and reconstruct upper and lower limb movements under different normal and pathological conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2022
CompletedFirst Submitted
Initial submission to the registry
May 28, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
February 12, 2025
February 1, 2025
5.9 years
May 28, 2024
February 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
step length and distance
Validate the algorithms developed to analyze the signals from the various sensors contained in magneto-inertial control units and reconstruct upper and lower limb movements.
36 months
Study Arms (1)
Patient with neuromuscular disease or control subjects
EXPERIMENTALPatients and controls will be examined by a neuropediatric or neurologist. they will perform upper and lower limb assessments in a walking laboratory. this study comprises a single session per patient/control subject.
Interventions
Subjects will be equipped with magneto-inertial sensors (ActiMyo®/Syde®) and passive reflective markers belonging to the MoCap® motion capture system.
Eligibility Criteria
You may qualify if:
- Subjects over 2 years old
- Male or female
- Control subjects with no pathologies that have an impact on ambulation or motor function.
- Signed informed consent and, in the case of minors, informed consent signed by the person with parental authority/guardian
You may not qualify if:
- Any other previous or present pathology having an impact on current motor or balance function
- For control subjects, athlete of at least national level.
- Pregnant or breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laurent Servaislead
- SYSNAVcollaborator
Study Sites (1)
CHR citadelle
Liège, Liege, 4000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor Laurent Servais
Study Record Dates
First Submitted
May 28, 2024
First Posted
June 3, 2024
Study Start
August 24, 2022
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
February 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share